International Journal of Clinical Pharmacology and Therapeutics
2009-01-01
Pharmacokinetic study of S-1.
B Mende, J Krauss, D Thyssen, S Kredtke, M E Scheulen, D Strumberg, A Hanauske, L Makris, P Scigalla, P D Urrea, R A Hilger
Index: Int. J. Clin. Pharmacol. Ther. 47(1) , 65-7, (2009)
Full Text: HTML
Abstract
Related Articles:
beta-alanine and alpha-fluoro-beta-alanine concentrative transport in rat hepatocytes is mediated by GABA transporter GAT-2.
1999-01-01
[Am. J. Physiol. 276(1 Pt 1) , G206-10, (1999)]
Proton-decoupled 19F spectroscopy of 5-FU catabolites in human liver.
1997-03-01
[Magn. Reson. Med. 37(3) , 321-6, (1997)]
The achievement of mass balance by simultaneous quantification of floxuridine prodrug, floxuridine, 5-fluorouracil, 5-dihydrouracil, α-fluoro-β-ureidopropionate, α-fluoro-β-alanine using LC-MS.
2011-04-15
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 879(13-14) , 915-20, (2011)]
Biochemical modulation of the catabolism and tissue uptake of the anticancer drug 5-fluorouracil by 5-bromovinyluracil: assessment with metabolic (19)F MR imaging.
1999-11-01
[Magn. Reson. Med. 42(5) , 936-43, (1999)]
Alternative pharmacokinetics of S-1 components, 5-fluorouracil, dihydrofluorouracil and alpha-fluoro-beta-alanine after oral administration of S-1 following total gastrectomy.
2007-10-01
[Cancer Sci. 98(10) , 1604-8, (2007)]